chrisvoncsefalvay/vaers-outcomes huggingface dataset:
1st dose 05May2021; 2nd dose 31Jul2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 05May2021; 2nd dose 31Jul2021) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Jul-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 05May2021; 2nd dose 31Jul2021). On 31-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose 05May2021; 2nd dose 31Jul2021) had resolved.            The concomitant medications information was not reported. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable.
15 monitoring status. Syncope episode after release from Monitoring (outside). Escorted back to monitoring area in w/c. Evaluated by Paramedics. SaO2 98% P 110 BP 142/84.  2:50PM feels "normal" hold until 3 and re-evaluate. 3:05mstands w/o dizziness.  W/c  escort to car.  Home
Patient and his wife received Meningococal Conjugate instead of Meningococcal Polysaccaride. Patient was 60 and wife 59 at the time of administration.
alopecia.  Hair falling out in patches approximately 1/2" to 3/4" in diameter.  2 bald patches yesterday increased to 5 patches today.
Vaccine was administer to 16 year old.  Moderna is only for patients older than 18 years. Per patient parent there was no allergic / adverse reaction.
Headache, vomiting, fever, chills, pinkeye, and herpes on lip.
Complained of chest pressure within 5 minutes of receiving vaccine. Pulse=90. Team was called and taken to ER.
Throat scratchy and tickly. Cough to clear throat.  Took 50 mg Benadryl with relief of symptoms
pt experienced warmth and redness at and around injection site. swollen, moved down towards elbow. no pain. pt was recommended to keep an eye on it and use over the counter remedies to relieve symptoms. is following up with pcp for further evaluation.
vaccine administered 05/22/2022 , beyond use date was 4/18/2022, expiration date was 5/31/2022
Patient was extremely anxious prior to vaccine.  She told me she did get seizures but she took medication for it and I informed her that it would still be recommended to get the vaccine.  She was visibly anxious even after vaccine.  Immediately after she began crying to her friend and said she "was just SO afraid of needles".  I told her to take some deep breaths and after a minute or two she went to the observation room.  Approximately 15 minutes later she rushed back into the room looking like she might hyperventilate or have hypoglycemia (shaking, cold sweats).  She sat down and I tried to calm her down.  I asked someone to get her orange juice.  During the next couple minutes she did not seem to be getting any better and started shaking.  I requested someone call 911.  Another staff was helping so I moved to get and administer an epi-pen injection.  By this time the patient was not responsive, but was still breathing.  I instructed staff to help move her to the floor for monitoring and if needed, cpr.  She regain partial consciousness.  Her breath and pulse were always present, so there was no need to begin cpr.  After a few minutes EMT arrived and transported patient to local hospital.  During all of this, other employees at the facility were attempting to contact family members, which they were eventually able to do. About 30 minutes later the staff informed me they had spoken to family members who were at the hospital and that she was improving, but they had not seen her yet.
She got her vaccine, had headaches, dizziness after the vaccine.  Then she felt a lump on her left foot, can feel it if she touches it.  She went to a doctor on 6/1/21 and did an x-ray and said that there was a chip in her foot.  She was informed that she would need surgery to remove the chip.     It feels like she is undergoing electronic torture, and still experiences that.  This feeling contracts all over her body since the chip was electronic and she feels it everywhere.    She then got her 2nd vaccine and then realized that the reaction she has (chip) was from the first vaccine.
Location: left arm pain. Quality: heaviness. Severity: worsening. Duration: present <1 month; started yesterday at 3pm. Timing: constant. Context: had pneumonia shot last week and arm started hurting yesterday; coughing, body pain, hurts to move left arm; pain all over; not sure what is going on; feels feverish; felt fine after shot on Friday and Saturday; 3pm yesterday started with body aches, left arm pain and hard to move; feels Had.
Patient was feeling nauseous after the vaccination. Went and ate lunch. When she came back from lunch, she passed out and a code blue was called. She never lost a pulse, but when in the ER she could not speak. She responded to commands without speaking. About 30 minutes later, she finally spoke.
Warm to touch to left arm including around the elbow; Redness to left arm including around the elbow; Swelling to left arm including around the elbow; Unsure if the injection site was muscle or subcutaneous; A spontaneous report was received from a healthcare professional concerning a 95-year-old, male consumer who developed redness, swelling, warm to touch after receiving a second dose of Moderna's COVID-19 vaccine administered at inappropriate site.  The patient's medical history was not provided. No relevant concomitant medications were reported.  The patient received their first of two planned doses of mRNA-1273 (Lot number:039k20a) intramuscularly in the right arm on 30 Dec 2020. On 26 Jan 2021, approximately 3 days prior to the onset of the symptoms, patient received their second of two planned doses of mRNA-1273 (Lot number: 012M20A) unknown route of administration in the left arm for prophylaxis of COVID-19 infection.  The patient was administered mRNA-1273 vaccine incorrectly, on 26 JAN 2021. On 29 Jan 2021 redness, swelling, and warm to touch noted to all the left arm including around the elbow. Treatment for the event include Benadryl(diphenhydramine) onetime only dose and cold compress. Area circled with marker.    The patient received both scheduled dose of mRNA-1273 prior to the event; therefore, action taken with the drug in response to the event is not applicable.  The event, vaccine administered at inappropriate site, was considered resolved. The outcome for the events redness, swelling and warm to touch, was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Left arm where vaccine was administered was red, hot and swollen.  He was vomiting and had a low-grade fever - about 100.0 F.
fever 100.0 Fahrenheit; chills; muscle aches; wiped out it is difficult for her to stand up; she hasn't been able to get out of bed for 3 days; Initial information received on 20-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-health care professional.  This case involves a 67 month-old female patient who experienced fever 100.0 Fahrenheit (pyrexia), chills, muscle aches (myalgia), wiped out it is difficult for her to stand up (fatigue), she hasn't been able to get out of bed for 3 days (bedridden), while she received INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV].  Medical history, medical treatment, vaccination, concomitant medication and family history were not provided. She was allergic to: IVP dye and Clyndamycin  On an unknown date, the patient received once 0.5 ml dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (pre-filled syringe) (lot UJ442AA and expiry date 30-Jun-2021) via unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, the patient developed non-serious fever 100.0 Fahrenheit (pyrexia), chills, muscle aches (myalgia), wiped out it is difficult for her to stand up (fatigue), she hasn't been able to get out of bed for 3 days (bedridden) following the administration of INFLUENZA QUADRIVAL A-B VACCINE (unknown latency).  Patient did not receive any corrective treatment.  At the time of report, patient had not recovered from the events.
Fever 12 hrs., chills, congestion/upper respiratory drainage, cough and fatigue. Cold symptoms lasted 3 days, fatigue 7 days. Fever/chills only 12 hours. Treated with Tylenol 500mg and lots of water and sleep.
Body aches (across entire body); Lethargy/Need to sleep; Fever (100-101F); Pain at injection site; Headache; Nausea; This is a spontaneous report received from a contactable consumer, the patient. A 49-years-old male patient received his second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247] via an unspecified route of administration in left arm on 16Mar2021 at 08:30 (at the age of 49-year-old) as a single dose, for COVID-19 immunisation. Medical history included hypertension, since unknown dates. The patient did not have any allergies to food, medications, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested positive for COVID-19. The patient did not receive any other vaccines within two weeks prior to the vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3247) via an unspecified route of administration in left arm on 23Feb2021 at 08:30 as a single dose for COVID-19 immunisation. The patient experienced fever (100-101F), body aches (across entire body) (general body pain), pain at injection site (vaccination site pain), lethargy/need to sleep, headache and nausea on 17Mar2021 at 08:00. The patient underwent lab tests and procedures, which included body temperature on 17Mar2021 and the result was 100-101F. The patient did not receive any treatment for the events. The clinical outcome of events fever, general body pain, vaccination site pain, lethargy, headache and nausea were recovering.   No follow-up attempts are needed. No further information is expected.
Case fully vaccinated with Moderna  with second dose administered on 2/4/2021. Tested positive for COVID 19 on 10/17/2021. Was admitted to hospital on 10/14/2021. Expired on 10/19/2021 while still hospitalized.
Headache chills Narrative:  The patient reported having a headache and chills the morning after receiving the vaccine. She denied any treatment measures.
Swollen and red at injection site. Tired. Nauseous. Muscle paint. Head ache.
I got the vaccine on 3/6 around 2:45pm. My arm was sore immediately. Around 8:00pm I was cold and then that  progressed to chills all night. By the morning of 3/7, I had a headache and my body was achy.  At 7:00am, I had a 102 degree fever which lasted all day. Body aches, headache and chills lasted all day 3/6. At 10:00pm 3/7 my fever was down to 99.9. I still had a dull headache and felt dizzy on the morning of 3/8. Fatigue through the afternoon of 3/8.
Information has been received from a physician and a healthcare office worker concerning a patient who on 14-AUG-2007 and 16-AUG-2007 was vaccinated with the first and second oral dose of Rotateq (Lot# 656705/0241U). The patient was not experiencing any known symptoms. Medical attention was sought via physician's office by phone. There was no product quality complaint. Additional information has been requested.
VIIS ID: 7827510; Moderna COVID-19 Vaccine Vaccine Lot Number: 025B21A  second dose. Vax clinic. Pt received vaccine in vehicle-unable to walk inside-family member stated that about 10mins after vaccine she began nodding off and was difficult to wake. 16:10: 123/80 POX 80% CPR not indicated. EMS On-site. S/S hypoxia, altered mental consciousness, unresponsive then alert. Family stated that she has been exhibiting similar symptoms recently-today is a 'bad day'. Son stated that it has been a difficult day for her. She has had to stop to "catch her breath' numerous times. "nods off' frequently. Assessment completed by EMS; transported to Hospital (doctors).
A report has been received from a Health Professional concerning a 6 year old, male subject, who had been receiving FLUMIST (Intranasal). FLUMIST (Intranasal) started on 14-Jan-2014. The health professional stated that patient was administered expired dose of FLUMIST which started on 14-Jan-2014. The outcome of the event of ADMINISTRATION OF EXPIRED DOSE is unknown. The report was considered to be non-serious.
Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Medium, Additional Details: No systemic allergic reaction symtpoms or SOB/throat tightness reported to RPh. Temperature on 3/31/2021 98.4. Encouraged patient to contact PCP to see if additoinal care or medications are needed. Patient reported using CBD over injection site to alleviate redness/swelling. Patient is not in pain, but has some limitations to arm function due to swelling at injection site.
Received Rotarix without reconstitute with the powder / only / diluent; Received Rotarix without reconstitute with the powder / only / diluent; This case was reported by a nurse via call center representative and described the occurrence of inappropriate preparation of medication in a 2-month-old male patient who received Rota (Rotarix lyophilized formulation) (batch number H395H, expiry date 30th September 2022) for prophylaxis.   Co-suspect products included rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis.   On 7th June 2021, the patient received Rotarix lyophilized formulation (oral) and Rotarix Oral Applicator Device. On 7th June 2021, unknown after receiving Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced inappropriate preparation of medication and inappropriate dose of vaccine administered. On an unknown date, the outcome of the inappropriate preparation of medication and inappropriate dose of vaccine administered were unknown.   This report is made without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: Nurse reported that the patient received Rotarix without reconstitute with the powder, only the diluent component was administered, which led to inappropriate preparation of medication and inappropriate dose of vaccine administered. No other information was provided. The reporter consented to follow up.
Pt reports knot at injection site. She also reports pain when lifting her arms or picking anything up. She states she will go to urgent care in the morning (12/6/18). Patient saw her doctor who thought it was probably fluid retention, with possible nerve or muscle damage, need further testing.
moderate amount of systemic itching; This is a spontaneous report from a contactable consumer(patient).A 70-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EL0264), via an unspecified route of administration, administered in right arm on 01Feb2021 at 16:00 as 1st dose, single, for COVID-19 immunization. The patient had history of allergies. Patient's medical history included type 2 diabetes mellitus, hypertension and osteoarthritis. The other medications in two weeks included topiramate, losartan, ibuprofen and propranolol. The patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection. Lot Number: EN6202), via an unspecified route of administration, administered in right arm on 23Feb2021 as 2nd dose, single, for COVID-19 immunization. The patient premeditated with 50 mg of Benadryl one hour before the second vaccination and every 5-6 hours for 3 days subsequently. As expected, itching was worse second time, but tolerable. The patient did not had Covid prior vaccination and did not tested Covid post vaccination. On 01Feb2021 at 16:30, the patient experienced moderate amount of systemic itching which was partially relieved by 25 mg of oral benadryl and local application of benadryl gel. The outcome of event was recovered in 2021.    No follow-up attempts are possible. No further information is expected.
pt recvd vax & 2 days later devel fever (104.5 ax) & vomiting aspirated & devel pneumonia was hospitlaized 4 days; 3MAR93 still has spot on lung & requires chest P.T. @ home;
Given Hepatitis A vaccine right arm. No reaction. Gave HPV vaccine #3 left arm, syncope in chair, pallor. Regained consciousness spontaneously.  Given ice pack to cool (pt. c/o feeling hot) and fluids (water).
lightheadedness, not sure of her footing and not walking as forcefully as usual; When she turned around she felt like she didn't have control.; lightheadedness, not sure of her footing and not walking as forcefully as usual; When she turned around she felt like she didn't have control.; lightheadedness, not sure of her footing and not walking as forcefully as usual; When she turned around she felt like she didn't have control.; arm hurt a little; This is a spontaneous report from a contactable consumer (patient). An 88-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL9263), on the right arm, via an unspecified route of administration on 25Jan2021 at 13:45 at single dose for COVID-19 immunisation. Medical history was reported as none. No family medical history. Concomitant medication included denosumab (PROLIA) given on 06Jan2021. No additional vaccine administered at the same date as BNT162B2 and no prior vaccinations within 4 weeks. No tests were done. On 26Jan2021, it was reported that her arm hurt a little but not much. A day or so later on 27Jan2021, the patient started to experience a lightheadedness, not sure of her footing and not walking as forcefully as usual. When she turned around she felt like she didn't have control. Adds she felt like she walking through a field of marshmallows. She is scheduled to receive the next dose of the vaccine on 15Feb2021 at 14:00. The events did not require physician office or emergency room visit. The vaccine was administered in a school. The outcome of the event arm hurt a little was recovered on 27Jan2021 while for the rest of the events was recovering.
Patient and his twin brother both developed colds I am guessing from a depressed immune system one week after their shots. Three other members of the family got the 24 hr flu exactly one week later as well after about a decade of never having had the flu. I'm curious about viral shedding and if the hib vaccine virus can infect close contacts.
plaintiffs allege that as a result of vax on 18APR90, pt exp high grade fever & convuls, & that periodic episodes of high grade fever, stiffness, & severe convuls cont;
Within a minute of receiving vaccine, pt had a 10 sec seizure, monitored in chair, VS taken, did not remember what happened. 5 minutes later he felt dizzy with semi LOC again, pt placed in supine position with feet elevated, recurrent VS taken which were stable throughout every 5 minutes for 15 more minutes. Pt stable, released with precautions for potential anaphylaxis symptoms. ER precautions discussed.
Swollen forearm itching, tender, red, soreness  over one week and swelling is getting worse
The date of PCR COVID test was 06Jul2021 and she was positive for COVID; The date of PCR COVID test was 06Jul2021 and she was positive for COVID/ she had no symptoms at all; This is a spontaneous report from a contactable consumer, the patient. This report is for the reporter herself (wife). A 57-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in left arm deltoid area on 12Feb2021 (at the age of 57-years-old) (Batch/Lot Number: EN6201; Expiration Date: 30Jun2021) as dose 2, 0.3 ml single and dose 1 via an unspecified route of administration, administered in left arm deltoid area on 22Jan2021 (at the age of 57-years-old) (Batch/Lot Number: EL3302; Expiration Date: 31May2021) as DOSE 1, 0.3 ML SINGLE for covid-19 immunization. Vaccine administered at Military Facility reported as no. Medical history reported as none. There were no concomitant medications. Family Medical History Relevant to AE: Not Provided. Prior Vaccinations (within 4 weeks): none. AE following prior vaccinations: Not Provided. Additional Vaccines Administered on Same Date of the Pfizer Suspect: None. Caller was reporting side effect to Pfizer COVID Vaccine. Caller and her husband both travelled to (privacy) where they got COVID19 infection and they both had received both doses of COVID19 Vaccine, wife (patient) said she had no symptoms at all after getting the infection. The caller was pleased that the vaccine worked with her not having symptoms and she just wanted to make sure it got documented because they got COVID19 infection when in the (privacy). The date of PCR COVID test was 06Jul2021 and she was positive for COVID. She stayed in quarantine for 10 days. Stop date would be the 16Jul2021 and she recovered completely. The patient underwent lab tests and procedures which included sars-cov-2 test which was positive on 06Jul2021. Description of Product Complaint: Traveled to (privacy) where she got COVID19 infection. She had received both doses of COVID19 Vaccine. she had no symptoms at all after getting the infection. The caller is pleased that the vaccine worked with her not having symptoms. She just wanted to make sure it got documented because she got COVID19 infection when in the (privacy). The date of PCR COVID test was 06Jul2021 and she was positive for COVID. The events had not resulted in emergency room/ physician office visit. The outcome of the event Asymptomatic COVID-19 was recovered on 16Jul2021 and vaccination failure was unknown.  Information on the lot/ batch number is available. Additional information has been requested.
The day after receiving the vaccine, I experienced common side effects of fever, chills, body aches, and nausea, which lasted for 24 hours, and then I felt better. Then, 3 days after receiving the vaccine, I suddenly began to have extreme stomach pain, so bad that I could barely walk or stand up straight. My chest felt tight and I had shortness of breath. I thought about going to the ER, but called my GI specialist instead as I thought it could be related to the Xifaxan I was taking, but the office was already closed. The GI office called the following Monday and said the Xifaxan should not cause extreme stomach pain and to go to the ER if it persists, but by this time I was feeling much better. The severe pain lasted two days in total.
Patient received live vaccine while pregnant (smallpox). Also received Anthrax, and Typhoid. Pt reported to immunization clinic 23 Oct 2008 to report she was 9 weeks pregnant.
No additional adverse events reported; improperly stored vaccines may have been administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, and previous drugs reactions or allergies were not provided.  On 17-DEC-2019, the patient was vaccinated with an improperly stored (product storage error) hepatitis a vaccine, inactivated (VAQTA), (Therapy type: Digital Data Logger), lot number S002506 and expiration date 04-APR-2020 for prophylaxis (strength, dose, dose number, frequency, route of administration, and anatomical location, were not provided).  The vaccine was stored at a temperature above 47 degree Fahrenheit (47.1 Fahrenheit), for a timeframe of 8 to 16 minutes, with no previous temperature excursion. The call was due to a Digital Data Logger.  No additional adverse events were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA009007: